Lack of hemodynamic effects after extended heme synthesis inhibition by succinylacetone in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 1, 2010, Pages 290-296

  Bourque, Stephane L ^a   Benjamin, Carling D ^a   Adams, Michael A ^a   Nakatsu, Kanji ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; GUANYLATE CYCLASE; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; SUCCINYLACETONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; HEART RATE; HEME SYNTHESIS; HEMODYNAMICS; HYPERTENSION; KIDNEY; LIVER; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PULSE PRESSURE; RAT; SENSITIVITY ANALYSIS; SODIUM EXCRETION; SODIUM INTAKE; SPLEEN; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; TELEMETRY; TREATMENT FAILURE; URINE LEVEL; VASCULAR TISSUE; VASODILATATION;

AMINOLEVULINIC ACID; ANIMALS; BLOOD PRESSURE; GUANYLATE CYCLASE; HEME; HEMODYNAMICS; HEPTANOATES; HYPERTENSION; KIDNEY; MALE; NITRIC OXIDE SYNTHASE; ORGAN SPECIFICITY; PORPHOBILINOGEN SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SODIUM;

EID: 77949733425     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.162966     Document Type: Article

References (40)

1. Andersson C and Lithner F (1994) Hypertension and renal disease in patients with acute intermittent porphyria. J Intern Med 236:169-175.
2. Banting JD, Thompson KE, Friberg P, and Adams MA (1997) Blunted cardiovascular growth induction during prolonged nitric-oxide synthase blockade. Hypertension 30:416-421.
3. Batuman V, Landy E, Maesaka JK, and Wedeen RP (1983) Contribution of lead to hypertension with renal impairment. N Engl J Med 309:17-21.
4. Bonkovsky HL (2005) Neurovisceral porphyrias: what a hematologist needs to know, in Hematology, pp 24-30, American Society of Hematology, Washington, DC.
5. Bourque SL, Komolova M, Nakatsu K, and Adams MA (2008) Long-term circulatory consequences of perinatal iron deficiency in male wistar rats. Hypertension 51:154-159.
6. Christensen E, Jacobsen BB, Gregersen N, Hjeds H, Pedersen JB, Brandt NJ, and Baekmark UB (1981) Urinary excretion of succinylacetone and δ-aminolevulinic acid in patients with hereditary tyrosinemia. Clin Chim Acta 116:331-341.
7. Church SE, McColl KE, Moore MR, and Youngs GR (1992) Hypertension and renal impairment as complications of acute porphyria. Nephrol Dial Transplant 7:986-990.
8. Cowley AW Jr and Roman RJ (1996) The role of the kidney in hypertension. J Am Med Assoc 275:1581-1589.
9. De Braekeleer M and Larochelle J (1990) Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean. Am J Hum Genet 47:302-307.
10. Gibbs TC, Payan J, Brett EM, Lindstedt S, Holme E, and Clayton PT (1993) Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase. J Neurol Neurosurg Psychiatry 56:1129-1132.
11. Herman MA, Webber J, Fromm D, and Kessel D (1998) Hemodynamic effects of 5-aminolevulinic acid in humans. J Photochem Photobiol B 43:61-65.
12. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, and Balla G (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood 100:879-887.
13. Karbownik M and Reiter RJ (2002) Melatonin protects against oxidative stress caused by δ-aminolevulinic acid: implications for cancer reduction. Cancer Invest 20:276-286.
14. Kimura KA, Parr AM, and Brien JF (1996) Effect of chronic maternal ethanol administration on nitric-oxide synthase activity in the hippocampus of the mature fetal guinea pig. Alcohol Clin Exp Res 20:948-953.
15. Kinobe RT, Vlahakis JZ, Vreman HJ, Stevenson DK, Brien JF, Szarek WA, and Nakatsu K (2006) Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal heme oxygenase isoforms. Br J Pharmacol 147:307-315.
16. Klujber V, Sallai A, Kalmanchey R, Szonyi L, and Hosszu E (1997) Late-onset type I tyrosinemia. Orv Hetil 138:1805-1808.
17. Majid DS and Navar LG (1997) Nitric oxide in the mediation of pressure natriuresis. Clin Exp Pharmacol Physiol 24:595-599.
18. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, and Davidson BL (1998) Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82:1298-1305.
19. Moncada S and Higgs EA (2006) Nitric oxide and the vascular endothelium. Handbk Exp Pharmacol 176:213-254.
20. Morrison GR (1965) Fluorometric microdetermination of heme protein. Anal Chem 37:1124-1126.
21. Nakamura K, Tanaka Y, Mitsubuchi H, and Endo F (2007) Animal models of tyrosinemia. J Nutr 137:1556S-1560S; discussion 1573S-1575S.
22. Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, and Alam J (2000) The indispensability of heme oxygenase-1 in protecting against acute heme proteininduced toxicity in vivo. Am J Pathol 156:1527-1535.
23. Nemsadze K, Sanikidze T, Ratiani L, Gabunia L, and Sharashenidze T. (2009) Mechanisms of lead-induced poisoning. Georgian Med News 172-173:92-96.
24. Newcomer SC, Taylor JC, McAllister RM, and Laughlin MH (2008) Effects of chronic nitric-oxide synthase inhibition on endothelium-dependent and -independent relaxation in arteries that perfuse skeletal muscle of swine. Endothelium 15:17-31.
25. Ni Z, Morcos S, and Vaziri ND (1997) Up-regulation of renal and vascular nitricoxide synthase in iron-deficiency anemia. Kidney Int 52:195-201.
26. Pirkle JL, Schwartz J, Landis JR, and Harlan WR (1985) The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemiol 121:246-258.
27. Rees D, Ben-Ishay D, and Moncada S (1996) Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant sabra rat. Hypertension 28:367-371.
28. Rosen P, Ballhausen T, Bloch W, and Addicks K (1995) Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38:1157-1168.
29. Russo PA, Mitchell GA, and Tanguay RM (2001) Tyrosinemia: a review. Pediatr Dev Pathol 4:212-221.
30. Salom MG, Lahera V, Miranda-Guardiola F, and Romero JC (1992) Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol Renal Physiol 262:F718-F722.
31. Sassa S and Kappas A (1982) Succinylacetone inhibits δ- aminolevulinate dehydratase and potentiates the drug and steroid induction of δ-aminolevulinate synthase in liver. Trans Assoc Am Physicians 95:42-52.
32. Schierbeek H, Beukeveld GJ, van Faassen H, van Spronsen FJ, Bijsterveld K, Venekamp-Hoolsema EE, Wolthers BG, and Smit GP (1993) Hereditary tyrosinaemia type I: a long-term study of the relationship between the urinary excretions of succinylacetone and δ-aminolevulinic acid. J Inherit Metab Dis 16:1034-1040.
33. Schlump JU, Perot C, Ketteler K, Schiff M, Mayatepek E, Wendel U, and Spiekerkoetter U (2008) Severe neurological crisis in a patient with hereditary tyrosinaemia type I after interruption of NTBC treatment. J Inherit Metab Dis doi: 10.1007/s10545-008-0807-z.
34. Soong J, Adams MA, and Nakatsu K (2008) Acute depletion of heme by succinylacetone alters vascular responses but does not induce hypertension. Can J Physiol Pharmacol 86:613-619.
35. Strife CF, Zuroweste EL, Emmett EA, Finelli VN, Petering HG, and Berry HK (1977) Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels. J Pediatr 90:400-404.
36. Thachil J (2008) Nitric oxide and the clinical manifestations of acute porphyria. Intern Med J 38:732-735.
37. Tschudy DP, Hess RA, and Frykholm BC (1981) Inhibition of δ-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid. J Biol Chem 256:9915-9923.
38. Tuchman M, Freese DK, Sharp HL, Ramnaraine ML, Ascher N, and Bloomer JR (1987) Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation. J Pediatr 110:399-403.
39. Wang R, Shamloul R, Wang X, Meng Q, and Wu L (2006) Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48:685-692.
40. Zou AP and Cowley AW Jr (1999) Role of nitric oxide in the control of renal function and salt sensitivity. Curr Hypertens Rep 1:178-186.